Pages

▼
Showing posts with label Oncolytic_Virus_Therapies. Show all posts
Showing posts with label Oncolytic_Virus_Therapies. Show all posts
Wednesday, 14 February 2018

DNX-2401 oncolytic adenovirus phase 1 trial results

›
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma ( cli...
Wednesday, 1 November 2017

DNX-201 With Pembrolizumab (Keytruda)

›
Hello All, I am looking for any comments, experience and suggestions with the DNX-2401 trial. The Phase II just opened and I am enrolled...
2 comments:
Friday, 29 September 2017

TG6002 oncolytic and vectorized virus, clinical trial for recurrent GBM in France

›
This upcoming trial in France is comparable to the Toca511/TocaFC trials in the US, in that it uses a viral vector to transmit a "suici...
Wednesday, 13 September 2017

Immunotheraphy combo

›
Do you have any experience or thoughts about this study? http://www.practiceupdate.com/c/57122/67/12/?elsca1=emc_enews_weekinreview&els...
2 comments:
Friday, 7 July 2017

Updated statistics from Duke's modified poliovirus trial for recurrent GBM

›
As of 2/01/2017, 52 pts were treated on study (1 each at DL1 and DL3, 7 at DL2, 2 at DL4, 4 at DL5, 24 at DL-1 and 13 at DL-2) 20.8% of ...
5 comments:
Monday, 27 February 2017

Upcoming trial of modified poliovirus for children ages 12-18 with recurrent malignant glioma

›
The anticipated start date is June of this year. Phase Ib Study of Oncolytic Polio/Rhinovirus Recombinant Against Recurrent Malignant Glio...
6 comments:
Tuesday, 27 December 2016

Brain Research Institute

›
I found this link on ABTA and thought it was helpful.  http://www.cancerresearch.org/cancer-immunotherapy/impacting-all-cancers/brain-ca...